Ramos GP - Search Results

1

The Use of Biologics for the Treatment of Esophageal Crohn Disease.

Lui J, Ramos GP, Codipilly DC, Katzka D, Raffals LE. Lui J, et al. Among authors: ramos gp. Inflamm Bowel Dis. 2021 Aug 19;27(9):1544-1547. doi: 10.1093/ibd/izab070. Inflamm Bowel Dis. 2021. PMID: 34050661 No abstract available.

2

Persistence of Nondysplastic Barrett's Esophagus Is Not Protective Against Progression to Adenocarcinoma.

Krishnamoorthi R, Ramos GP, Crews N, Johnson M, Dierkhising R, Shi Q, Ginos B, Wang K, Katzka D, Buttar N, Iyer PG. Krishnamoorthi R, et al. Among authors: ramos gp. Clin Gastroenterol Hepatol. 2017 Jun;15(6):950-952. doi: 10.1016/j.cgh.2017.02.019. Epub 2017 Feb 24. Clin Gastroenterol Hepatol. 2017. PMID: 28238955 No abstract available.

3

Targeting Specific Immunologic Pathways in Crohn's Disease.

Ramos GP, Faubion WA, Papadakis KA. Ramos GP, et al. Gastroenterol Clin North Am. 2017 Sep;46(3):577-588. doi: 10.1016/j.gtc.2017.05.009. Epub 2017 Jul 19. Gastroenterol Clin North Am. 2017. PMID: 28838416 Review.

4

De-novo Inflammatory Bowel Disease After Bariatric Surgery: A Large Case Series.

Braga Neto MB, Gregory M, Ramos GP, Loftus EV Jr, Ciorba MA, Bruining DH, Bazerbachi F, Abu Dayyeh BK, Kushnir VM, Shah M, Collazo-Clavell ML, Raffals LE, Deepak P. Braga Neto MB, et al. Among authors: ramos gp. J Crohns Colitis. 2018 Mar 28;12(4):452-457. doi: 10.1093/ecco-jcc/jjx177. J Crohns Colitis. 2018. PMID: 29272375

5

Outcomes of Treatment for Latent Tuberculosis Infection in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy.

Ramos GP, Stroh G, Al-Bawardy B, Faubion WA, Papadakis KA, Escalante P. Ramos GP, et al. Inflamm Bowel Dis. 2018 Sep 15;24(10):2272-2277. doi: 10.1093/ibd/izy133. Inflamm Bowel Dis. 2018. PMID: 29718223

6

Vedolizumab Drug Level Correlation With Clinical Remission, Biomarker Normalization, and Mucosal Healing in Inflammatory Bowel Disease.

Al-Bawardy B, Ramos GP, Willrich MAV, Jenkins SM, Park SH, Aniwan S, Schoenoff SA, Bruining DH, Papadakis KA, Raffals L, Tremaine WJ, Loftus EV. Al-Bawardy B, et al. Among authors: ramos gp. Inflamm Bowel Dis. 2019 Feb 21;25(3):580-586. doi: 10.1093/ibd/izy272. Inflamm Bowel Dis. 2019. PMID: 30165638

7

Impact of Bariatric Surgery on the Long-term Disease Course of Inflammatory Bowel Disease.

Braga Neto MB, Gregory MH, Ramos GP, Bazerbachi F, Bruining DH, Abu Dayyeh BK, Kushnir VM, Raffals LE, Ciorba MA, Loftus EV, Deepak P. Braga Neto MB, et al. Among authors: ramos gp. Inflamm Bowel Dis. 2020 Jun 18;26(7):1089-1097. doi: 10.1093/ibd/izz236. Inflamm Bowel Dis. 2020. PMID: 31613968 Free PMC article.

8

Use of Immune Checkpoint Inhibitors in Patients With Pre-established Inflammatory Bowel Diseases: Retrospective Case Series.

Braga Neto MB, Ramos GP, Loftus EV Jr, Faubion WA, Raffals LE. Braga Neto MB, et al. Among authors: ramos gp. Clin Gastroenterol Hepatol. 2021 Jun;19(6):1285-1287.e1. doi: 10.1016/j.cgh.2020.06.031. Epub 2020 Jun 19. Clin Gastroenterol Hepatol. 2021. PMID: 32565289

9

The Impact of Vedolizumab on Pre-Existing Extraintestinal Manifestations of Inflammatory Bowel Disease: A Multicenter Study.

Ramos GP, Dimopoulos C, McDonald NM, Janssens LP, Hung KW, Proctor D, Ruggiero E, Kane S, Bruining DH, Faubion WA, Raffals LE, Loftus EV, Al-Bawardy B. Ramos GP, et al. Inflamm Bowel Dis. 2021 Jul 27;27(8):1270-1276. doi: 10.1093/ibd/izaa293. Inflamm Bowel Dis. 2021. PMID: 33165569

10

The Impact of Alcohol in Inflammatory Bowel Diseases.

White BA, Ramos GP, Kane S. White BA, et al. Among authors: ramos gp. Inflamm Bowel Dis. 2022 Mar 2;28(3):466-473. doi: 10.1093/ibd/izab089. Inflamm Bowel Dis. 2022. PMID: 33988227

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

64 results

Search Page

Filters